NO115800B - - Google Patents

Info

Publication number
NO115800B
NO115800B NO155542A NO15554264A NO115800B NO 115800 B NO115800 B NO 115800B NO 155542 A NO155542 A NO 155542A NO 15554264 A NO15554264 A NO 15554264A NO 115800 B NO115800 B NO 115800B
Authority
NO
Norway
Prior art keywords
piperazine
pyrimidine
general formula
denotes
benzyl
Prior art date
Application number
NO155542A
Other languages
English (en)
Norwegian (no)
Inventor
G Regnier
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of NO115800B publication Critical patent/NO115800B/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO155542A 1963-11-19 1964-11-12 NO115800B (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB45685/63A GB1101425A (en) 1963-11-19 1963-11-19 New pyrimidine derivatives

Publications (1)

Publication Number Publication Date
NO115800B true NO115800B (fr) 1968-12-09

Family

ID=10438157

Family Applications (1)

Application Number Title Priority Date Filing Date
NO155542A NO115800B (fr) 1963-11-19 1964-11-12

Country Status (14)

Country Link
US (1) US3299067A (fr)
AT (1) AT255421B (fr)
BE (1) BE655431A (fr)
BR (1) BR6464358D0 (fr)
CH (1) CH437310A (fr)
DE (1) DE1297610B (fr)
DK (1) DK115995B (fr)
ES (1) ES306226A1 (fr)
FI (1) FI46163C (fr)
FR (1) FR4770M (fr)
GB (1) GB1101425A (fr)
NL (2) NL6413349A (fr)
NO (1) NO115800B (fr)
SE (1) SE322521B (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980781A (en) * 1966-03-31 1976-09-14 Imperial Chemical Industries Limited Fungicidal composition and method containing 2-amino-pyrimidines
GB1143167A (en) * 1967-01-25 1969-02-19 Ucb Sa Derivatives of pyrimidine
GB1369379A (en) * 1972-04-07 1974-10-09 Science Union & Cie Benzodioxole derivatives and processes for preparing them
US3988457A (en) * 1974-02-07 1976-10-26 Smithkline Corporation Novel compounds and compositions for treating Parkinson's disease
US3919230A (en) * 1974-02-07 1975-11-11 Smithkline Corp {62 -Naphthylmethyl piperazinyl derivatives
US3960863A (en) * 1974-06-25 1976-06-01 Sankyo Company Limited Pyrido[1,2-a]pyrimidinone derivatives
US4166852A (en) * 1974-08-09 1979-09-04 Produits Chimiques Ugine Kuhlmann Piperazino-pyrimidines and their use as spasmolytic agents
OA06083A (fr) * 1977-11-09 1981-06-30 Science Union & Cie Ste Franca Nouvelles pipérazines disubstituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant.
FR2519986A1 (fr) * 1982-01-21 1983-07-22 Adir Nouveaux derives de benzodioxine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
FR2539990A1 (fr) * 1983-01-28 1984-08-03 Sanofi Sa Composition pharmaceutique a action psychotrope dopaminergique contenant une 2-piperazinopyrimidine
US4605655A (en) * 1984-03-06 1986-08-12 Bristol-Myers Company Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives
US4980350A (en) * 1988-02-25 1990-12-25 Merck & Co., Inc. Piperazinylalkylpyrimidines as hypoglycemic agents
EP0330263A1 (fr) * 1988-02-25 1989-08-30 Merck & Co. Inc. Pipérazinylalkylpyrimidines comme agents hypoglycémiques
US4994460A (en) * 1989-06-01 1991-02-19 Bristol-Myers Squibb Co. Agents for treatment of brain ischemia
US5859246A (en) 1997-01-30 1999-01-12 Neurogen Corporation 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands
EP1032559B1 (fr) * 1997-09-29 2006-11-29 Aventis Pharmaceuticals Inc. Derives d'aminoalkylphenols pour traiter la depression et le dysfonctionnement de la memoire
US6825198B2 (en) * 2001-06-21 2004-11-30 Pfizer Inc 5-HT receptor ligands and uses thereof
CN1681495B (zh) 2002-08-19 2010-05-12 辉瑞产品公司 用于治疗过度增生性疾病的组合物
CN1910159A (zh) * 2004-01-16 2007-02-07 诺瓦提斯公司 2,4-二氨基嘧啶和它们用于诱导心肌发生的用途
US7241891B2 (en) * 2004-03-29 2007-07-10 Chung-Shan Institute Of Science & Technology Method for the purification of Piribedil
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのcetp阻害剤としてのn−((3−ベンジル)−2,2−(ビス−フェニル)−プロパン−1−アミン誘導体
CN101735201B (zh) * 2009-12-17 2012-05-30 宁夏康亚药业有限公司 一种吡贝地尔的制备方法
CN101830891A (zh) * 2010-05-18 2010-09-15 沈阳药科大学 一种吡贝地尔的制备方法
EP2986599A1 (fr) 2013-04-17 2016-02-24 Pfizer Inc. Dérivés de n-pipéridin-3-ylbenzamide dans le traitement des maladies cardiovasculaires
JP6563017B2 (ja) 2014-08-28 2019-08-21 エースニューロン・ソシエテ・アノニム グリコシダーゼ阻害剤
WO2016055901A1 (fr) 2014-10-08 2016-04-14 Pfizer Inc. Composés d'amide substitué
WO2018153508A2 (fr) 2017-02-24 2018-08-30 Asceneuron S.A. Inhibiteurs de la sulfoximine glycosidase
EP3419971B1 (fr) 2016-02-25 2022-04-20 Asceneuron SA Inhibiteurs de glycosidases
KR20180132060A (ko) 2016-02-25 2018-12-11 아셰뉴론 에스아 피페라진 유도체의 산 부가 염
MX2018010191A (es) 2016-02-25 2019-05-20 Asceneuron S A Inhibidores de glucosidasa.
US11261183B2 (en) 2016-02-25 2022-03-01 Asceneuron Sa Sulfoximine glycosidase inhibitors
CN106432212B (zh) * 2016-09-21 2019-01-11 苏州弘森药业股份有限公司 一种合成吡贝地尔的方法
CN107163032A (zh) * 2017-06-19 2017-09-15 太仓卡斯特姆新材料有限公司 一种高收率的吡贝地尔制备方法
CN107266429A (zh) * 2017-06-19 2017-10-20 太仓大唐化纤厂 一种高品质的吡贝地尔制备方法
CN107216318A (zh) * 2017-06-19 2017-09-29 太仓弘杉环保科技有限公司 一种吡贝地尔制备方法
CN107417674B (zh) * 2017-06-26 2020-12-29 苏州弘森药业股份有限公司 一种吡贝地尔的提纯方法
EP3672958B1 (fr) 2017-08-24 2023-08-02 Asceneuron SA Inhibiteurs de glycosidases annelés
EP3672959A1 (fr) 2017-08-24 2020-07-01 Asceneuron SA Inhibiteurs linéaires de la glycosidase
RU2737721C2 (ru) * 2017-12-15 2020-12-02 Алексей Георгиевич Александров Способ получения фармацевтической субстанции на основе пирибедила
WO2020039029A1 (fr) 2018-08-22 2020-02-27 Asceneuron S. A. Composés spiro utilisés en tant qu'inhibiteurs de glycosidases
WO2020039028A1 (fr) 2018-08-22 2020-02-27 Asceneuron S. A. Inhibiteurs de tétrahydro-benzoazépine glycosidase
US12016852B2 (en) 2018-08-22 2024-06-25 Asceneuron Sa Pyrrolidine glycosidase inhibitors
BR112021013807A2 (pt) 2019-01-18 2021-11-30 Astrazeneca Ab Inibidores de pcsk9 e seus métodos de uso
WO2020169804A1 (fr) 2019-02-22 2020-08-27 Asceneuron Sa Inhibiteurs de glycosidases fusionnés

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE485737A (fr) * 1947-11-12
DE942029C (de) * 1951-06-22 1956-04-26 American Cyanamid Co Verfahren zur Herstellung von neuen, in 1-Stellung substituierten 4-Aminopiperazinderivaten
US3078214A (en) * 1958-09-12 1963-02-19 Sandoz Ag Treatment of mental disturbances with esters of indoles
US2979508A (en) * 1959-10-12 1961-04-11 Paul A J Janssen Heterocyclic derivatives of 1-phenyl-omega-(piperazine) alkanols
US2985657A (en) * 1959-10-12 1961-05-23 Paul A J Janssen 1-(aroylalkyl)-4-heterocyclylpiperazines
US3141820A (en) * 1960-10-31 1964-07-21 Merck & Co Inc Coccidiosis control composition
BE618035A (fr) * 1961-05-26
US3144387A (en) * 1961-06-30 1964-08-11 Parke Davis & Co Anti-inflammatory compositions

Also Published As

Publication number Publication date
BE655431A (fr) 1965-05-06
ES306226A1 (es) 1965-03-01
US3299067A (en) 1967-01-17
GB1101425A (en) 1968-01-31
CH437310A (fr) 1967-06-15
FR4770M (fr) 1967-01-23
NL6413349A (fr) 1965-05-20
SE322521B (fr) 1970-04-13
DE1297610B (de) 1969-06-19
NL127996C (fr)
FI46163C (fi) 1973-01-10
FI46163B (fr) 1972-10-02
DK115995B (da) 1969-12-01
AT255421B (de) 1967-07-10
BR6464358D0 (pt) 1973-07-26

Similar Documents

Publication Publication Date Title
NO115800B (fr)
CA1165318A (fr) Quinazolines agissant comme agent antihypertenseur
US4323570A (en) Substituted aminopyrimidines
US4430343A (en) Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same
Zanatta et al. Haloacetylated enol ethers. 9. Synthesis of 4‐trifluoromethyl‐2‐methyl [phenyl] pyrimidines and tetrahydro derivatives
DE3876813T4 (de) 3(2H)Pyridazinon, Verfahren zu dessen Herstellung und dieses enthaltendes Mittel gegen SRS-A.
GB2087881A (en) 5-substituted methyl-pyrimidine-2,4-diamines
JPH06179673A (ja) 新規なピペラジンおよびホモピペラジン誘導体、これらの化合物を含有する医薬組成物およびこれらの化合物の製法
DD216934A5 (de) Verfahren zur herstellung neuer derivate von xanthinen
US6469168B1 (en) Piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the active substance
US4010267A (en) Benzodioxole compounds
DE2849537A1 (de) Substituierte 5-(2-imidazolin-2-yl)- aminopyrimidine und verfahren zu deren herstellung
US4535080A (en) Derivatives of 2-piperazino-pyrimidine, methods for their preparation and their utilization as drugs or intermediates for drugs
EP0044704B1 (fr) Pyrimidine-2-ones substituées, leurs sels, procédés pour leur préparation, compositions pharmaceutiques les contenant
DE9290039U1 (de) Pyrimidinderivate zur Verbesserung der Anti-Tumor-Aktivität
US3830811A (en) 2,6-bis-allylaminopyrimidinyl piperazines
NZ206906A (en) Substituted pyridazines and pyrimidines and pharmaceutical compositions
DE3027106C2 (fr)
US3757017A (en) 4,5 polymethylene pyrimidine derivatives
NO155542B (no) Fremgangsmaate ved fremstilling av ikke-toksiske styren-, acryl- eller epoxyharpikser med kolesterolspeilnedsettende egenskaper.
US4775673A (en) Substituted acylpiperazinoquinazolines and pharmaceutical compositions containing same
NO810870L (no) Fremgangsmaate til fremstilling av pyrimidylkinazoliner
EP1003728B1 (fr) Fumarate de 2-(3-(4-(2-t-butyl-6-trifluorométhylpyrimidin-4-yl)pipérazin-1-yl)propylmercapto)pyrimidin-4-ol
CA1071627A (fr) Derives de la pyrimidine
US3290306A (en) Certain 2-oxyalkyl-4-halogenopyrimidines and intermediates therefor